Malaria Treatment

Source: www.ncbi.nlm.nih.gov --- 7 days ago
Related Articles Effectiveness of co-artemether in an unsupervised outpatient setting for the Treatment of falciparum Malaria. Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):29-31 Authors: Toovey S OBJECTIVES: To assess artemether-lumefantrine effectiveness in the Treatment of falciparum Malaria in an unsupervised outpatient setting in Africa. DESIGN: Open label prospective study. SETTING: Occupational health clinic, Mozambique. SUBJECTS: Semi-immune Mozambican adults. OUTCOME MEASURES: 28-day Treatment failures. RESULTS: 54/54 subjects were smear negative on day 2, and at 'day 28' (range 26-34 days). CONCLUSIONS: Artemether-lumefantrine is effective in semi-immune adults in an unsupervised outpatient setting in Southern Africa, with no evidence of recrudescence. PMID: 18342270 [PubMed - indexed for MEDLINE] ...

Source: www.ncbi.nlm.nih.gov --- 26 days ago
Related Articles Determinants of provider choice for Malaria Treatment: Experiences from The Gambia. Soc Sci Med. 2008 Jun 4; Authors: Wiseman V, Scott A, Conteh L, McElroy B, Stevens W Malaria is responsible for an estimated one million deaths per year, the vast majority in sub-Saharan Africa. Many of these deaths are attributed to delays in seeking Treatment and poor adherence to drug regimes. While there are a growing number of studies describing the factors influencing Treatment seeking for Malaria, far less is known about the relative weight given to these factors in different settings. This study estimates two models of demand for Malaria Treatment in the Farafenni region of The Gambia. The first examines the determinants of seeking Malaria Treatment outside the home versus no Treatment or self-care while the second identifies the determinants of provider choice conditional on having decided to seek Malaria Treatment outside the home. Providers included hospital; health centre; and 'other' which included pharmacies, kiosks; petty traders; neighbours; and traditional healers. Results show that older people were more likely to opt for self-care, or no Treatment. The longer the time spent ill or the more severe the fever, the more likely a Treatment was sought outside the home. Time of the year and availability of community infrastructure played a key role in both models. Poorer households and those from the Fula ethnic group were m ...

Source: www.moreover.com --- 35 days ago
The Minister of Health, Major (RTD) E.K. Quarshigah has announced that the government and her development partners spend $774 million annually on Treatment of Malaria cases in the country. ...

Source: www.ncbi.nlm.nih.gov --- 14 days ago
Related Articles Early Treatment of imported falciparum Malaria in the intermediate and intensive care unit setting: an 8-year single-center retrospective study. Crit Care. 2008;12(1):R22 Authors: Schwake L, Streit JP, Edler L, Encke J, Stremmel W, Junghanss T INTRODUCTION: Imported falciparum Malaria is characterized by a broad spectrum of potentially life-threatening complications that may arise even after initiation of appropriate antimalarial drug therapy. Hence, at Heidelberg University Hospital, all patients with newly diagnosed falciparum Malaria are initially treated in the intermediate care unit (IMC) or intensive care unit (ICU). The present study was undertaken to evaluate critically the benefit of this strategy, which includes daily consultation with senior specialists in tropical medicine. METHODS: We conducted a retrospective cohort study at the 14-bed combined IMC/ICU of a 1,685-bed university hospital. A cohort of 122 patients with imported falciparum Malaria admitted from 1 January 1996 to 31 December 2003 was included. RESULTS: Thirty-four patients (27.9%) developed complications, defined according to the current World Health Organization classification. Most patients (80.3%) studied did not take the recommended chemoprophylaxis against Malaria. The majority of patients (89.3% [n = 109]) could be adequately treated in the IMC. Life-threatening complications requiring ICU support occurred in 13 patients (10.7%). All c ...

Source: www.army.mil --- 35 days ago
Brig. Gen. Rhonda Cornum, assistant surgeon general for force protection ...

Source: www.ncbi.nlm.nih.gov --- 3 days ago
Related Articles Atovaquone-proguanil resistance in imported falciparum Malaria in a young child. Pediatr Infect Dis J. 2008 Jun;27(6):567-9 Authors: Rose GW, Suh KN, Kain KC, Le Saux N, McCarthy AE We discuss a case of atovaquone-proguanil Treatment failure in a child from Mozambique, recently arrived in North America. Four weeks after completing therapy, symptomatic parasitemia recurred, caused by Plasmodium falciparum parasites bearing a Tyr268Ser mutation in cytochrome b. We review the literature concerning atovaquone-proguanil resistance, and emphasize the importance of follow-up and consideration of resistance where patients have relapsed symptoms. PMID: 18434932 [PubMed - indexed for MEDLINE] ...

Source: www.ncbi.nlm.nih.gov --- 3 days ago
Related Articles Moderate-to-Severe Anaemia due to Afebrile Plasmodium falciparum Infection in Children aged 6-23 Months from the Rural District of Kongoussi, Burkina Faso. J Trop Pediatr. 2008 Jul 3; Authors: Ouédraogo HZ, Zeba A, Dramaix-Wilmet M, Donnen P A population-based cross-sectional study was conducted to investigate the association of haemoglobin concentration and moderate-to-severe anaemia with afebrile Plasmodium falciparum (PF) infection in 456 rural children aged 6-23 months. Capillary blood was obtained for haemoglobin concentration measurement by HemoCue(R) and Malaria detection by blood smear microscopy. Anaemia was noted in 444 (97.4%) children with 194 (42.5%) being moderate-to-severe anaemia. PF infection was noted in 240 (52.6%) children with 117 (25.6%) being afebrile and 123 (27.0%) being febrile. Children with afebrile and those with febrile PF infection were more likely to have moderate-to-severe anaemia than children who were PF-free, with odds ratio (95% confidence interval) of 1.86 (1.07-3.23), p = 0.028 and 2.40 (1.29-4.48), p < 0.001, respectively. These results underline the high burden of both anaemia and PF infection in this population. Strategies aiming at controlling malarial anaemia and based on Malaria case-Treatment should consider both febrile and afebrile PF infection to allow for a better impact. PMID: 18599531 [PubMed - as supplied by publisher] ...

Source: www.ncbi.nlm.nih.gov --- 17 days ago
Related Articles Acute renal failure in Plasmodium malariae infection. Neth J Med. 2008 Apr;66(4):166-8 Authors: Neri S, Pulvirenti D, Patamia I, Zoccolo A, Castellino P We report an unusual case of transfusion-transmitted Malaria which remained undiagnosed for several months in an Italian woman splenectomised and polytransfused for thalassaemia major. The infecting species was Plasmodium malariae, and the patient developed acute renal failure, severe thrombocytopenia, and hepatic failure. Treatment with chlorochine was followed by a slow, but complete recovery of renal function. PMID: 18424865 [PubMed - indexed for MEDLINE] ...

Source: www.ncbi.nlm.nih.gov --- 37 days ago
Related Articles Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet. 2008 May 30; Authors: Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, Ryckman KK, Tacconelli A, Mariani-Costantini R, Novelli G, Soodyall H, Rotimi CN, Ramesar RS, Tishkoff SA, Williams SM Africa is the ultimate source of modern humans and as such harbors more genetic variation than any other continent. For this reason, studies of the patterns of genetic variation in African populations are crucial to understanding how genes affect phenotypic variation, including disease predisposition. In addition, the patterns of extant genetic variation in Africa are important for understanding how genetic variation affects infectious diseases that are a major problem in Africa, such as Malaria, tuberculosis, schistosomiasis, and HIV/AIDS. Therefore, elucidating the role that genetic susceptibility to infectious diseases plays is critical to improving the health of people in Africa. It is also of note that recent and ongoing social and cultural changes in sub-Saharan Africa have increased the prevalence of non-communicable diseases that will also require genetic analyses to improve disease prevention and Treatment. In this review we give special attention to many of the past and ongoing studies, emphasizing those in Sub-Saharan Africans that address the role of genetic variation in h ...

Source: www.ncbi.nlm.nih.gov --- 11 days ago
Related Articles Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum Malaria. PLoS ONE. 2008;3(3):e1779 Authors: Wootton DG, Opara H, Biagini GA, Kanjala MK, Duparc S, Kirby PL, Woessner M, Neate C, Nyirenda M, Blencowe H, Dube-Mbeye Q, Kanyok T, Ward S, Molyneux M, Dunyo S, Winstanley PA The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil-dapsone (CPG-DDS) for the Treatment of uncomplicated falciparum Malaria. METHODS: Open-label clinical trial comparing CPG-DDS alone or with artesunate 4, 2, or 1 mg/kg at medical centers in Blantyre, Malawi and Farafenni, The Gambia. The trial was conducted between June 2002 and February 2005, including 116 adults (median age 27 years) and 107 children (median age 38 months) with acute uncomplicated Plasmodium falciparum Malaria. Subjects were randomized into 4 groups to receive CPG-DDS alone or plus 4, 2 or 1 mg/kg of artesunate once daily for 3 days. Assessments took place on Days 0-3 in hospital and follow-up on Days 7 and 14 as out-patients. Efficacy was evaluated in the Day 3 per-protocol (PP) population using mean time to reduce baseline parasitemia by 90% (PC90). A number of secondary outcomes were also included. Appropriate artesunate dose was determined using a pre-def ...

Source: www.ncbi.nlm.nih.gov --- 23 days ago
Related Articles Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil. Prescrire Int. 2008 Apr;17(94):54-6 Authors: (1) Treatment of uncomplicated Malaria acquired in areas of chloroquine resistance is based on oral drugs chosen according to local resistance patterns. The atovaquone + proguanil combination is often the first choice for travelers because of its tolerability and convenience. (2) For the Treatment of uncomplicated Malaria, artemisinin derivatives, extracted from a Chinese plant, have a short-lived action and should not therefore be used as monotherapy. (3) Only one combination of this type, artemether plus lumefantrine (an antimalarial related to halofantrine), is marketed in France for the Treatment of uncomplicated Malaria. (4) In African trials, the efficacy of the artemether + lumefantrine combination, taken in 6 doses over 3 days, was fairly consistent and similar (or even superior) to that of the amodiaquine + sulfadoxine + pyrimethamine combination in three trials. It was more effective than the quinine + doxycycline combination in a region of Brazil where strains with diminished sensitivity to quinine circulate. (5) Artemether has the adverse effects of all artemisinin derivatives, especially gastrointestinal and neurological disorders. Lumefantrine, a drug related to halofantrine, prolongs the QT interval (albeit less than halofantrine), and this sometimes warrants ECG monitoring and blo ...

Source: news.com.au --- 36 days ago
BRISBANE researchers have found that Great Barrier Reef organisms may provide a Treatment for Malaria and won international acclaim for their work. ...

Source: www.metafilter.com --- 35 days ago
Rehabilitating Carson: "Why do some people continue to hold Rachel Carson responsible for millions of Malaria deaths?" A reply: Contra John Quiggin and Tim Lambert, DDT is usually the most cost-effective anti-Malaria Treatment, and remains scandalously underused More on the debate, including links to the authors' replies to Bate: Big Tobacco and the war on science ...

Source: www.huffingtonpost.com --- 28 days ago
Today, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced that 1.75 million people with HIV/AIDS around the world are receiving lifesaving anti-retroviral (ARV) drug Treatment for free through Global Fund-financed programs. This number highlights the significant progress that has been made in the fight against HIV/AIDS since the inception of the Global Fund in 2002 when only approximately 300,000 of people in need of ARVs were on Treatment. These numbers are proof that the U.S.'s investment in the Global Fund, a public-private partnership funding programs to eliminate the world's most deadly yet preventable diseases, is working. Through the President's Emergency Plan for AIDS Relief (PEPFAR), the U.S. contribution to the Global Fund has significantly helped provide infrastructure, prevention and Treatment services, food and free ARV Treatment to those infected and affected by AIDS around the world. More than ever before, more people are receiving the Treatment they need and thankfully, are living longer, healthier lives. This is a life-long commitment, so it is critical for the U.S. to maintain its strong support. The AIDS pandemic is the greatest public health challenge the world has ever faced. It has ravaged populations across countries and socio-economic status, hitting the parts of the world hardest where access to even basic health care and infrastructure are at best, limited. Yet as evidenced by the numbers j ...

Source: blog.beliefnet.com --- 31 days ago
Sometimes I think I have become immune to Washington, D.C., feeling as though nothing can shock or surprise me, and then I hear a story that brings my expectations to an all-time low. Seven senators -- known as the “Coburn Seven” -- are playing politics with the lives of millions of people affected by deadly diseases by blocking the reauthorization of the Global AIDS, Malaria and Tuberculosis bill. AIDS, Malaria, and tuberculosis cause more than 90 percent of all deaths from infectious diseases around the world. A bill that will help fight these diseases passed in the U.S. House and has strong presidential support, but the “Coburn Seven” have blocked it from coming to a vote in the Senate. They say they want a mandate to shift money from prevention to Treatment, but this argument is a fool’s errand; for every person who goes on Treatment, there are 2.5 people newly diagnosed. The Global AIDS, Malaria and Tuberculosis program includes special provisions for orphans, women, and girls -- some of the hardest-hit populations in disease-ravaged villages and neighborhoods. These Treatment and prevention programs are more than charity: They invest in local clinics and pharmacies and train nurses and doctors. They reach beyond the tired prevention debate of abstinence versus contraception and address a broad array of real-world factors that lead to infections, such as gender violence, unsanitary housing, and education. Next month President Bush ...

Source: upcoming.yahoo.com --- 9 days ago
This exhibition is a joint initiative of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Magnum Photos. A team of eight photographers traveled to nine countries to document the impact of free antiretroviral drug Treatment for AIDS patients across the globe. The result is a somber yet extraordinarily uplifting and inspirational testament to the benefits of the drugs and international funding. ...

Source: tailrank.com --- 3 days ago
LONDON (Reuters) - Brazil launched a new Treatment for Malaria on Thursday, marking the latest step in a global program to make cheap two-in-one pills available to millions at risk from the mosquito-borne killer. A mosquito that was caught in a trap is held by tweezers. The drug is not protected by ... ...

Source: www.washingtontimes.com --- 16 days ago
Colombian and Indonesian troops have been drafted to test new anti-Malaria drugs. South African researchers used Tanzanian soldiers to study the effectiveness of an unorthodox Treatment for HIV/AIDS. ...

Source: www.medicalnewstoday.com --- 35 days ago
The Royal College of Pathologists and the Health Protection Agency have won a highly prestigious Gold Medal at this year's Chelsea Flower Show. The joint exhibition explores the possibility that climate change may increase the risk of Malaria returning to the UK. Visitors are able to find out which species of mosquito transmit Malaria, the plants used in the prevention and Treatment of Malaria, and how pathologists diagnose and treat the disease. ...

Source: www.buzzflash.com --- 23 hours ago
A BUZZFLASH NEWS ALERT by Amy Weiss Pressure is mounting for the Senate to pass a comprehensive global health bill that will provide $50 billion for Treatment of HIV/AIDS, tuberculosis, and Malaria in the developing world. The bill to reauthorize the President's Emergency Plan for AIDS Relief (PEPFAR) passed the House in April and has strong bipartisan support in the Senate. Local papers have begun to criticize their Senators for continuing to oppose the bill or failing to demonstrate leadership on it. Bookmark/Search this post with: buzzflash | delicious | digg | technorati Technorati Tags: Alerts PEPFAR global health HIV/AIDS G8 Bush McConnell read more ...